Home › NDC Lookup › RxCUI directory › RxCUI 2398512

{9 (Once-Daily gabapentin 300 MG Oral Tablet [Gralise]) / 24 (Once-Daily gabapentin 600 MG... — RxCUI 2398512

RxNorm drug concept · Brand name pack
RxCUI 2398512 Brand name pack · BPCK ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2398512
Official name{9 (Once-Daily gabapentin 300 MG Oral Tablet [Gralise]) / 24 (Once-Daily gabapentin 600 MG Oral Tablet [Gralise]) } Pack [Gralise Sample Pack]
Concept typeBrand name pack (BPCK)
RxNorm statusCurrent RxNorm concept
Also known asGralise 15-Day Sample Pack; Gralise Sample Pack
FDA products mapped5
Package NDCs mapped5
Reported Medicaid activity (SDUD)1,184 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Gabapentin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Gabapentin is mainly used for two things: managing nerve pain that lingers after a shingles infection (called postherpetic neuralgia) in adults, and helping control partial onset s...
  • This is a really important question. Taking gabapentin together with opioids like morphine, hydrocodone, or oxycodone significantly raises the risk of serious breathing problems —...
  • Can I take gabapentin with my opioid pain medication?
  • The most common ones — especially in the first few weeks — are dizziness, drowsiness, and sometimes loss of balance or coordination. Swelling in the feet or hands is also fairly co...
📖 Read our full Gabapentin guide →

🕸️ Concept Web — How {9 (Once-Daily gabapentin 300 MG Oral Tablet [Gr... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {9 (Once-Daily gabapentin 300 MG Oral Tablet [Gralise]) / 24 (Once-Daily gabapentin 600 MG Oral Tablet [Gralise]) } Pack [Gralise Sample Pack] RxCUI 2398512

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Gabapentin 25480
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Gralise 1087976
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Gabapentin Oral Tablet 378099
    • Gabapentin Oral Product 1156681
    • Gabapentin Pill 1156682
    • Gabapentin Oral Tablet [Gralise] 1115011
    • Gralise Oral Product 1172653
    • Gralise Pill 1172654
    • Pack 746839
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 8

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 19 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 2398512 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
52427-0803-90 90 TABLET, FILM COATED in 1 BOTTLE (52427-803-90) Gralise Almatica Pharma LLC 2020-10-01
52427-0804-60 60 TABLET, FILM COATED in 1 BOTTLE (52427-804-60) Gralise Almatica Pharma LLC 2023-12-31
52427-0806-90 90 TABLET, FILM COATED in 1 BOTTLE (52427-806-90) Gralise Almatica Pharma LLC 2020-10-01
52427-0850-60 60 TABLET, FILM COATED in 1 BOTTLE (52427-850-60) Gralise Almatica Pharma LLC 2023-12-31
52427-0890-60 60 TABLET, FILM COATED in 1 BOTTLE (52427-890-60) Gralise Almatica Pharma LLC 2023-12-31
Observed labelers: Almatica Pharma LLC (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.